Can glaucoma eye drops protect eye nerve cells?
Part of Eyes & vision clinical trials.
This study looks at whether a common class of glaucoma eye drops (called prostaglandin analogues) can protect the nerve cells in the back of the eye. It may help people with certain types of glaucoma who have been stable on one type of eye drop for at least 3 years.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with a specific type of glaucoma (like open-angle or normal tension glaucoma) in at least one eye
- You have been using only one type of glaucoma eye drop (either a prostaglandin analogue or a different kind) for at least 3 years
- You have had at least 6 eye check-ups over the past 3 years, including tests for vision field and eye structure
- You have not had any glaucoma surgery other than laser trabeculoplasty or cataract surgery during that time
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational eye drop called ASP2767 to see if it is safe and can help slow or prevent further vision loss in people with advanced glaucoma-related optic nerve damage.
This study looks at how the optic nerve (the part of your eye that sends images to your brain) strains or bends in people who do not have glaucoma. It uses advanced eye imaging and home pressure checks to understand the nerve's health.
This study tests how the eye drop Rocklatan (a combination of latanoprost and netarsudil) affects blood flow in the back of the eye for people with early open-angle glaucoma. If you already use latanoprost but your eye pressure is still 17 or higher, this trial may explore if adding another medicine improves optic nerve health.
This Phase 1 study tests an insulin-based eye treatment to see if it’s safe and potentially helpful for people with glaucoma-related optic nerve damage. If you may be eligible, you’ll have a close eye exam and repeated vision testing, mainly focused on one study eye.
This trial tests whether NAD precursor supplements can improve nerve health and vision in people with glaucoma. If you have glaucoma with mild to moderate vision loss, this study may help understand if these supplements could protect your optic nerve.
This trial tests whether a home-based exercise program can lower eye pressure and protect the optic nerve in people with glaucoma. It is designed for patients whose eye pressure is already controlled by medication.
Hear when a new Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.